A month after announcing it was seeking strategic alternatives, Akili Interactive, maker of a video game designed to treat ADHD, said it will go private in a merger with Virtual Therapeutics. The deal ...
BOSTON--(BUSINESS WIRE)--Akili, Inc. (Nasdaq: AKLI), a leading digital therapeutics company, today announced U.S. Food and Drug Administration (FDA) clearance of EndeavorOTC Ⓡ (AKL-T01) as an over-the ...
Akili Interactive Labs, a digital therapeutics company that’s developed a video game to improve attention deficit hyperactivity disorder, has closed a $55 million Series C round financing. The fresh ...
Akili (NASDAQ:AKLI) stock rose ~38% on Wednesday after the company reported results from a trial of video game-based therapy EndeavorRx to treat adults with attention ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback